Ashton Tweed’s CEO Interviews!

September 1, 2011

CEO Leadership Series: Jane Hollingsworth, CEO, NuPathe

Originally published in Ashton Tweed Connection, September 2011 As market conditions and the economy continue to improve, the specialty pharmaceutical industry is expected to grow substantially […]
February 1, 2012

CEO Leadership Series: Christopher Cashman, Executive Chairman, Marinus Pharmaceuticals

THE RISKS AND REWARDS OF ENTREPRENEURSHIP Originally published in Ashton Tweed Connection, February 2012 What are the risks and rewards of entrepreneurship? That’s what we asked […]
April 1, 2012

CEO Leadership Series: Nick Spring, President & CEO, Rainbow Pharmaceuticals, Inc.

SUCCESSFULLY RIDING THE WAVE OF CHANGE IN PHARMA TODAY  Originally published in Ashton Tweed Connection, April 2012 In 2005, Nick Spring cofounded Topaz Pharmaceuticals — a […]
June 1, 2012

CEO Leadership Series: Dr. Warren Cooper, Former President & CEO, Prism Pharmaceuticals

SUCCESS STRATEGIES FOR NEW DRUG DEVELOPMENT TODAY Originally published in Ashton Tweed Connection, Summer 2012 As the former President and CEO of Prism Pharmaceuticals, Dr. Warren […]
September 1, 2012

CEO Leadership Series: Donna L. Tempel, PhD, President and CEO, Drais Pharmaceuticals, Inc.

USING VIRTUAL BIOTECHS TO MOVE DRUGS INTO DEVELOPMENT MORE EFFICIENTLY This year, Bridgewater, NJ-based Drais Pharmaceuticals, Inc., has launched a new business model. According to Drais […]
March 1, 2013

CEO Leadership Series: Baruch Ben Dor, PhD, President & CEO, InfraScan Inc.

A ROLLER-COASTER RIDE TO SUCCESS IN THE MEDICAL DEVICE INDUSTRY When someone gets a serious head injury, the prompt detection of intracranial bleeding can be a […]
April 17, 2014
David Johnson, CEO of Alliqua, Inc.

CEO Leadership Series: David Johnson, CEO, Alliqua, Inc.

MAKING A SMOOTH TRANSITION FROM A LARGE MEDICAL DEVICE FIRM TO A SMALL BIOPHARMACEUTICAL COMPANY Last year, David Johnson made a big change in his career […]
September 4, 2014
James E. Sapirstein, RPh., M.B.A.,CEO and director of ContraVir Pharmaceuticals, Inc.

CEO Leadership Series: James E. Sapirstein, CEO & Director, ContraVir Pharmaceuticals, Inc.

PRIVATE VS. PUBLIC COMPANY LEADERSHIP “To be successful as a chief executive officer, you have to know how to run an enterprise. You have to be […]
May 15, 2015
Dr. Warren Cooper, President, Coalescence Inc.

CEO Leadership Series: Dr. Warren Cooper, President, Coalescence Inc.

THE IMPORTANCE OF BUILDING A STRONG BOARD OF DIRECTORS The composition of a company’s board of directors ultimately can make or break a business. Warren Cooper, […]